Literature DB >> 31147421

Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults.

Val J Lowe1, Tyler J Bruinsma2, Heather J Wiste2, Hoon-Ki Min2, Stephen D Weigand2, Ping Fang2, Matthew L Senjem2, Terry M Therneau2, Bradley F Boeve2, Keith A Josephs2, Mukesh K Pandey2, Melissa E Murray2, Kejal Kantarci2, David T Jones2, Prashanthi Vemuri2, Jonathan Graff-Radford2, Christopher G Schwarz2, Mary M Machulda2, Michelle M Mielke2, Rosebud O Roberts2, David S Knopman2, Ronald C Petersen2, Clifford R Jack2.   

Abstract

OBJECTIVE: To assess cross-sectional associations of neurofibrillary tangles, measured by tau-PET, with cognitive performance in cognitively unimpaired (CU) adults.
METHODS: Tau- and amyloid-PET were performed in 579 CU participants aged 50-98 from the population-based Mayo Clinic Study of Aging. Associations between tau-PET signal in 43 brain regions and cognitive test scores were assessed using penalized linear regression. In additional models, participants were classified by normal/abnormal global amyloid-PET (A+/A-) and normal/abnormal regional tau-PET (T+/T-). Regional tau-PET cutpoints were defined as standardized uptake value ratio (SUVR) greater than the 95th percentile of tau-PET SUVR in that region among 117 CU participants aged 30-49.
RESULTS: Higher tau-PET signal was associated with poorer memory performance in all medial temporal lobe (MTL) regions and also in the middle temporal pole and frontal olfactory regions. The largest association with tau-PET and memory z scores was seen in the entorhinal cortex; this association was independent of tau-PET signal in other brain regions. Tau-PET in the entorhinal cortex was also associated with poorer global and language performance. In the entorhinal cortex, T+ was associated with lower memory performance among both A- and A+.
CONCLUSIONS: Tau deposition in MTL regions, as reflected by tau-PET signal, was associated with poorer performance on memory tests in CU participants. The association with entorhinal cortex tau-PET was independent of tau-PET signal in other brain regions. Longitudinal studies are needed to understand the fate of CU participants with elevated medial temporal tau-PET signal.
© 2019 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31147421      PMCID: PMC6659005          DOI: 10.1212/WNL.0000000000007728

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

1.  Tau PET in Alzheimer disease and mild cognitive impairment.

Authors:  Hanna Cho; Jae Yong Choi; Mi Song Hwang; Jae Hoon Lee; You Jin Kim; Hye Mi Lee; Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

2.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

3.  Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment.

Authors:  Robert S Wilson; Sue E Leurgans; Patricia A Boyle; David A Bennett
Journal:  Arch Neurol       Date:  2011-03

4.  Amyloid and tau PET demonstrate region-specific associations in normal older people.

Authors:  Samuel N Lockhart; Michael Schöll; Suzanne L Baker; Nagehan Ayakta; Kaitlin N Swinnerton; Rachel K Bell; Taylor J Mellinger; Vyoma D Shah; James P O'Neil; Mustafa Janabi; William J Jagust
Journal:  Neuroimage       Date:  2017-02-21       Impact factor: 6.556

5.  The role of the temporal pole in modulating primitive auditory memory.

Authors:  Zhiliang Liu; Qian Wang; Yu You; Peng Yin; Hu Ding; Xiaohan Bao; Pengcheng Yang; Hao Lu; Yayue Gao; Liang Li
Journal:  Neurosci Lett       Date:  2016-03-15       Impact factor: 3.046

6.  Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.

Authors:  Anne Maass; Samuel N Lockhart; Theresa M Harrison; Rachel K Bell; Taylor Mellinger; Kaitlin Swinnerton; Suzanne L Baker; Gil D Rabinovici; William J Jagust
Journal:  J Neurosci       Date:  2017-11-30       Impact factor: 6.167

7.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

8.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

9.  Primary age-related tauopathy (PART): a common pathology associated with human aging.

Authors:  John F Crary; John Q Trojanowski; Julie A Schneider; Jose F Abisambra; Erin L Abner; Irina Alafuzoff; Steven E Arnold; Johannes Attems; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Marla Gearing; Lea T Grinberg; Patrick R Hof; Bradley T Hyman; Kurt Jellinger; Gregory A Jicha; Gabor G Kovacs; David S Knopman; Julia Kofler; Walter A Kukull; Ian R Mackenzie; Eliezer Masliah; Ann McKee; Thomas J Montine; Melissa E Murray; Janna H Neltner; Ismael Santa-Maria; William W Seeley; Alberto Serrano-Pozo; Michael L Shelanski; Thor Stein; Masaki Takao; Dietmar R Thal; Jonathan B Toledo; Juan C Troncoso; Jean Paul Vonsattel; Charles L White; Thomas Wisniewski; Randall L Woltjer; Masahito Yamada; Peter T Nelson
Journal:  Acta Neuropathol       Date:  2014-10-28       Impact factor: 17.088

10.  An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Authors:  Val J Lowe; Geoffry Curran; Ping Fang; Amanda M Liesinger; Keith A Josephs; Joseph E Parisi; Kejal Kantarci; Bradley F Boeve; Mukesh K Pandey; Tyler Bruinsma; David S Knopman; David T Jones; Leonard Petrucelli; Casey N Cook; Neill R Graff-Radford; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Melissa E Murray
Journal:  Acta Neuropathol Commun       Date:  2016-06-13       Impact factor: 7.801

View more
  31 in total

1.  Reduced [18F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matter.

Authors:  Alexis Moscoso; Michel J Grothe; Michael Schöll
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-21       Impact factor: 9.236

2.  Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.

Authors:  Vijay K Ramanan; Michael G Heckman; Scott A Przybelski; Timothy G Lesnick; Val J Lowe; Jonathan Graff-Radford; M Mielke; Clifford R Jack; David S Knopman; Ronald C Petersen; Owen A Ross; Prashanthi Vemuri
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 3.  The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics.

Authors:  Eric Karran; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2022-02-17       Impact factor: 112.288

4.  The vascular risk factors and vascular neuropathology in subjects with autopsy-confirmed dementia with Lewy bodies.

Authors:  Zhi-Chao Chen; Jinghuan Gan; Yaqi Yang; Qingbo Meng; Jiuyan Han; Yong Ji
Journal:  Int J Geriatr Psychiatry       Date:  2022-03       Impact factor: 3.850

5.  Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease.

Authors:  Andrew J Aschenbrenner; Brian A Gordon; Anne M Fagan; Suzanne E Schindler; David A Balota; John C Morris; Jason J Hassenstab
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.

Authors:  Pontus Tideman; Erik Stomrud; Antoine Leuzy; Niklas Mattsson-Carlgren; Sebastian Palmqvist; Oskar Hansson
Journal:  Neurology       Date:  2022-01-12       Impact factor: 11.800

7.  A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.

Authors:  Shehroo B Pudumjee; Emily S Lundt; Sabrina M Albertson; Mary M Machulda; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Michelle M Mielke; Nikki H Stricker
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.

Authors:  Justin S Sanchez; J Alex Becker; Heidi I L Jacobs; Bernard J Hanseeuw; Shu Jiang; Aaron P Schultz; Michael J Properzi; Samantha R Katz; Alexa Beiser; Claudia L Satizabal; Adrienne O'Donnell; Charles DeCarli; Ron Killiany; Georges El Fakhri; Marc D Normandin; Teresa Gómez-Isla; Yakeel T Quiroz; Dorene M Rentz; Reisa A Sperling; Sudha Seshadri; Jean Augustinack; Julie C Price; Keith A Johnson
Journal:  Sci Transl Med       Date:  2021-01-20       Impact factor: 17.956

9.  Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly.

Authors:  Diego Z Carvalho; Erik K St Louis; Christopher G Schwarz; Val J Lowe; Bradley F Boeve; Scott A Przybelski; Ashritha Reddy; Michelle M Mielke; David S Knopman; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri
Journal:  Neurology       Date:  2020-03-26       Impact factor: 9.910

10.  Pathological correlates of impaired self-awareness of memory function in Alzheimer's disease.

Authors:  Geoffroy Gagliardi; Madeline Kuppe; Cristina Lois; Bernard Hanseeuw; Patrizia Vannini
Journal:  Alzheimers Res Ther       Date:  2021-06-25       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.